Cargando…

BSBM-12 STAT3 EXPRESSION IN BRAIN METASTASES FROM BREAST CANCER: CORRELATIONS WITH DIFFERENT MOLECULAR SUBTYPES AND CLINICAL OUTCOME

BACKGROUND: STAT3 expression in peritumoral reactive astrocytes (RA) of brain metastases (BM) from breast cancer (BC) may favor a pro-metastatic environment. MATERIAL AND METHODS: 105 BM specimens from BC were identified from the biobank of Pathology Unit of University of Turin and Spanish national...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pellerino, Alessia, Bruno, Francesco, Bertero, Luca, Bellini, Elisa, Beano, Alessandra, Montemurro, Filippo, Valiente, Manuel, Rudà, Roberta, Soffietti, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Final Category: Basic Science of Brain Metastases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402300/ http://dx.doi.org/10.1093/noajnl/vdad070.008

Ejemplares similares

BSBM-21 MACHINE LEARNING IDENTIFIES EXPERIMENTAL BRAIN METASTASIS SUBTYPES BASED ON THEIR INFLUENCE ON NEURAL CIRCUITS
por: Masmudi-Martin, Mariam, et al.
Publicado: (2023)

BSBM-16 HLA CLASS-I ANTIGEN PRESENTATION MACHINERY AND IFN-γ PATHWAY ALTERATIONS IN LUNG CANCER BRAIN METASTASES
por: Vilarino, Noelia, et al.
Publicado: (2023)

BSBM-07 HIGH-DIMENSIONAL HISTOPATHOLOGIC EVALUATION OF THE HYPOXIC MICROENVIRONMENT IN GLIOBLASTOMA
por: Mansouri, Sheila, et al.
Publicado: (2023)

BSBM-15 SYSTEMIC AND LOCAL IMMUNE RESPONSES FOLLOWING STEREOTACTIC RADIOSURGERY TO BRAIN METASTASES FROM HER2-AMPLIFIED BREAST CANCER
por: Sia, Joseph, et al.
Publicado: (2023)

BSBM-06 UNRAVELING THE IMMUNE MICROENVIRONMENT OF BRAIN METASTASIS FROM LUNG ADENOCARCINOMA
por: Souza, Vanessa G P, et al.
Publicado: (2023)

BSBM-10 CHARACTERIZATION OF A RADIATION-RESISTANT MODEL OF LUNG CANCER BRAIN METASTASIS
por: Wolford, Cullen, et al.
Publicado: (2023)

BSBM-17 NOVEL VALIDATED PATIENT-DERIVED MODELS OF A RECTAL CANCER BRAIN METASTASIS
por: Barros Guinle, Maria Isabel, et al.
Publicado: (2023)

BSBM-03 A NOVEL COMBINED IMMUNOTHERAPY TO IMPROVE THERAPEUTIC RESPONSES IN SYMPTOMATIC BRAIN METASTASIS BASED ON TARGETING A SUBPOPULATION OF IMMUNOSUPPRESSIVE ASTROCYTES
por: Priego, Neibla, et al.
Publicado: (2023)

BSBM-14 MOLECULAR PROFILING OF CHECKPOINT LIGANDS AND KEY NK-ACTIVATION AND SUPPRESSIVE LIGANDS BY METASTATIC MELANOMA CELLS
por: Anchan, Akshata, et al.
Publicado: (2023)

BSBM-13 MELANOMA CELLS PRODUCE A SUSPENSION SUB-POPULATION THAT DRASTICALLY DISRUPTS THE BLOOD-BRAIN BARRIER ENDOTHELIUM
por: Anchan, Akshata, et al.
Publicado: (2023)

BSBM-22 CHARACTERIZATION OF CIRCULATORY SHEAR STRESS-INDUCED MOLECULAR CHANGES IN LUNG ADENOCARCINOMA CELLS AND IMPLICATIONS IN BRAIN METASTASIS
por: Marenco-Hillembrand, Lina, et al.
Publicado: (2023)

BSBM-04 MULTIPLE MYELOMA METASTASIS TO THE PINEAL GLAND: A CASE REPORT FROM LONG ISLAND, NEW YORK, USA
por: Torres, Marielle, et al.
Publicado: (2023)

BSBM-19 CROSS-PRESENTATION BY TUMOR-ASSOCIATED MACROPHAGES MEDIATES THE TRANSITION FROM PROGENITOR TO TERMINAL T CELL EXHAUSTION IN PRIMARY AND METASTATIC BRAIN TUMORS
por: Polania, Jessica Waibl, et al.
Publicado: (2023)

BSBM-11 COMBINING IMMUNOTHERAPY AND WHOLE-BRAIN RADIATION THERAPY IN A NOVEL SYNGENEIC LUNG CANCER BRAIN METASTASIS PRECLINICAL MODEL: DOES TIMING OF ADMINISTRATION MATTER?
por: Blethen, Kathryn, et al.
Publicado: (2023)

BSBM-18 SINGLE-CELL PROFILING TUMOR-INFILTRATING IMMUNE CELLS REVEALS CXCL13(+) FOLLICULAR HELPER-LIKE CD4(+) T CELLS IN HUMAN BRAIN TUMORS
por: Lu, Benjamin, et al.
Publicado: (2023)

BSBM-20 INVESTIGATING THE ROLE OF OXIDATIVE PHOSPHORYLATION (OXPHOS) IN CD4+ T CELL ACTIVATION AND RESPONSE TO ANTI-PD1/ANTI-LAG3 IMMUNOTHERAPY IN MELANOMA BRAIN METASTASIS (MBM)
por: Guerrieri, Renato, et al.
Publicado: (2023)

BSBM-09 IN VIVO CRISPR ACTIVATION SCREEN IDENTIFIES ß-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) AS A DRIVER OF NON-SMALL CELL LUNG CANCER BRAIN METASTASIS
por: Chafe, Shawn, et al.
Publicado: (2023)

METASTASES-01 OUTCOME OF BRAIN METASTASES TREATED WITH GAMMA KNIFE STEREOTACTIC RADIOSURGERY (GKSR): COHORT RETROSPECTIVE STUDY ON 205 CASES
por: Bankole, Nourou Dine Adeniran, et al.
Publicado: (2023)

METASTASES-03 PREVALENCE AND CLINICAL SIGNIFICANCE OF UNSUSPECTED INTRACRANIAL FINDINGS IN PATIENTS UNDERGOING ONCOLOGICAL WHOLE BODY(18) F- FLUORODEOXYGLUCOSE (FDG) PET CT IMAGING.
por: Nyamieri, Diana Kerubo, et al.
Publicado: (2023)

Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments
por: Pellerino, Alessia, et al.
Publicado: (2018)

Targeted Therapies in Rare Brain Tumours
por: Bruno, Francesco, et al.
Publicado: (2021)

Leptomeningeal Metastases from Solid Tumors: Recent Advances in Diagnosis and Molecular Approaches
por: Pellerino, Alessia, et al.
Publicado: (2021)

Management of Brain and Leptomeningeal Metastases from Breast Cancer
por: Pellerino, Alessia, et al.
Publicado: (2020)

Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?
por: Pellerino, Alessia, et al.
Publicado: (2022)

Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance
por: Mo, Francesca, et al.
Publicado: (2021)

Ependymoma: Evaluation and Management Updates
por: Rudà, Roberta, et al.
Publicado: (2022)

Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?
por: Pellerino, Alessia, et al.
Publicado: (2023)

Patient and implant survival following joint replacement because of metastatic bone disease: A cross-sectional study of 130 patients with 140 joint replacements
por: Sørensen, Michala S, et al.
Publicado: (2013)

Glioblastoma in the Elderly: Review of Molecular and Therapeutic Aspects
por: Bruno, Francesco, et al.
Publicado: (2022)

Neratinib and Capecitabine for the Treatment of Leptomeningeal Metastases from HER2-Positive Breast Cancer: A Series in the Setting of a Compassionate Program
por: Pellerino, Alessia, et al.
Publicado: (2022)

Neurotoxicity from Old and New Radiation Treatments for Brain Tumors
por: Soffietti, Riccardo, et al.
Publicado: (2023)

NEIM-12 PRE- AND POST-TREATMENT RADIOLOGIC FEATURES AND VOLUMETRIC CHANGES LINKED TO TREATMENT RESPONSE OF BRAIN METASTASES AFTER LASER INTERSTITIAL THERMAL THERAPY (LITT)
por: Sanvito, Francesco, et al.
Publicado: (2023)

NEIM-02 CHARACTERIZATION OF LARGE BRAIN METASTASES WITH(18)F-FLUCICLOVINE PET/CT TREATED WITH STAGED STEREOTACTIC RADIOSURGERY (SSRS): INTERIM ANALYSIS OF A PILOT STUDY
por: Rosa, Alonso La, et al.
Publicado: (2023)

NEIM-05 PURSUE: RESULTS FROM A PROSPECTIVE, PHASE 2B TRIAL TO DEFINE IMAGE INTERPRETATION CRITERIA FOR(18)F-FLUCICLOVINE-PET FOR DETECTION OF RECURRENT BRAIN METASTASES AFTER RADIATION THERAPY
por: Kotecha, Rupesh, et al.
Publicado: (2023)

Modern management of pulmonary metastases (Preface)
por: Hekmat, Khosro
Publicado: (2021)

MDB-19. MULTIOMIC PROFILING OF MEDULLOBLASTOMA REVEALS SUBTYPE-SPECIFIC TARGETABLE ALTERATIONS AT THE PROTEOME AND N-GLYCAN LEVEL
por: Godbole, Shweta, et al.
Publicado: (2023)

TIPS-16 A PROSPECTIVE COHORT STUDY ON THE IMPACT OF RADIOTHERAPY ON QUALITY OF LIFE AND DISEASE PROGRESSION IN PATIENTS WITH BRAIN METASTASES AND THEIR CAREGIVERS
por: Cialdella, Fia, et al.
Publicado: (2023)

MDB-04. SINGLE-CELL TRANSCRIPTOMIC ANALYSIS REVEALS DISTINCT GENOMIC LANDSCAPES, CELL TRAJECTORIES, AND TUMOUR-MICROENVIRONMENT INTERACTIONS IN FOUR SUBTYPES OF MEDULLOBLASTOMA
por: Ruchiy, Yana, et al.
Publicado: (2023)

MDB-13. CURRENT STATUS OF DIAGNOSIS AND TREATMENT FOR HIGH-RISK STAGE M2/M3 NON-WNT SUBTYPES MEDULLOBLASTOMA IN SOUTH CHINA
por: Cai, Linbo, et al.
Publicado: (2023)

TIPS-15 NEUROCOGNITIVE FUNCTION AND NEUROCOGNITIVE CONCERNS IN AN ONGOING PHASE III TRIAL OF PRE-OPERATIVE SRS VERSUS POST-OPERATIVE SRS FOR BRAIN METASTASES
por: Wefel, Jeffrey, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kea6os5elcrrjip9nalfcou7br